Akifumi Notsu

Shizuoka Cancer Center

Papers

6

Total Citations

67

H-Index

3

About

Dr. Akifumi Notsu is a leading surgical oncologist whose research is redefining minimally invasive approaches to gastric and rectal cancer. His work centers on the precision and outcomes of robotic surgery, directly comparing it to conventional laparoscopic techniques. Dr. Notsu’s landmark 2021 study, with 39 citations, provided compelling evidence that robotic gastrectomy offers significant advantages over laparoscopy for clinical stage I/II gastric cancer patients. He further demonstrated that this robotic advantage is particularly pronounced in patients with high visceral fat, a population traditionally at higher risk for complications. Beyond gastric surgery, Dr. Notsu has made critical contributions to rectal cancer care. He has pioneered the study of predictors for difficult robotic splenic flexure mobilization and, in a highly cited 2024 work, clarified the relationship between autonomic nerve resection and postoperative urinary dysfunction. His investigations into risk factors for duodenal stump leakage and the impact of mesorectal fat on recurrence have directly informed safer surgical protocols. With a rapidly growing body of work that consistently addresses the most challenging aspects of oncologic surgery, Dr. Notsu is a pivotal figure in advancing the safety and efficacy of robotic cancer treatment.

Research Focus

Key Achievements

3
H-Index
6
Papers
67
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Gastrectomy Compared with Laparoscopic Gastrectomy for Clinical Stage I/II Gastric Cancer Patients: A Propensity Score‐Matched Analysis
39 citations · 2021
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Shizuoka Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago